Navigation Links
Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates
Date:12/22/2009

's approach to drug discovery."

Viron's second therapeutic candidate, VT-346, is a powerful inhibitor of TNF-a, the therapeutic target of Enbrel(TM), Humira(TM), Cimzia(TM) and Remicade(TM), which together share a market estimated at over $20 billion annually. In head to head testing, VT-346 has proven itself to be as much as 100 times more potent than some currently marketed therapeutics, due in part to a novel mechanism of action evolved by the original virus.

The latest patent for VT-346, US 7,585,507, entitled "Nucleic acid molecules and polypeptides for immune modulation", relates to the use of VT-346 in treating immuno-modulatory disorders characterized by inflammation, such as rheumatoid arthritis, transplant rejection, asthma and inflammatory bowel disease. The protection provided by this patent also extends out to at least 2021.

Viron recently received a Notice of Allowance from the US patent office for a patent on VT-384, a protein derived from the Yatapoxvirus that targets IL-18, a cytokine expressed at sites of chronic inflammation. This cytokine has been implicated in numerous autoimmune diseases and a variety of cancers.

"IL-18 is a target of keen interest to big Pharma, with several monoclonal antibody candidates targeting IL-18 in various stages of development. Viron's discovery platform identified this natural protein that targets IL-18, which falls outside the complicated anti-IL-18 antibody patent landscape. This has hindered development of some anti-IL-18 antibody approaches. As such, we believe the commercial prospects for VT-384 in diseases such as arthritis and COPD could be very significant," said James Rae, Chief Executive Officer of Viron Therapeutics. "These issued patents also highlight our ability to discover and develop unique therapeutics which reside within pathogens and which have had millions of years to perfect strategies to modulate the immune system."

About Viron Therapeutic
'/>"/>

SOURCE Viron Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
2. Landfill mining reduces environmental impact of growing waste
3. Landfill mining reduces environmental impact of growing waste
4. Nanowire generates power by harvesting energy from the environment
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. Environmental Tectonics Corporations BioMedical Division Announces New Contract
7. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
8. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
9. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
10. Nanotechs health, environmental impacts worry scientists and the public
11. Fixed C-Arms Revolutionize Operating Room Environments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 With the ability to record continuously ... more than 15 minutes, Fastec Imaging has brought the same ... speed imaging. “Finally, a high speed camera that can be ... our everyday lives.” proclaims Matt Kearney, VP of Sales for ... to demystify and simplify the traditionally complicated workflow of a ...
(Date:7/23/2014)... Columbia, MD (PRWEB) July 23, 2014 ... Booth and ChirpE Mobile App, AACC Pathfinder, in its ... event offerings. AACC’s annual meeting is planned for July ... is the place to be to connect with global ... medicine, lab management, and other areas of breaking science ...
(Date:7/23/2014)... Cambridge, MA (PRWEB) July 23, 2014 ... provider of innovative and comprehensive consultancy and pharma ... Research Excellence and Safety (ACRES) , a non-profit ... worldwide to build and maintain a global system ... strategic alliance collaboration to improve the expertise of ...
Breaking Biology Technology:Sofinnova Raises $500 Million Biotech Venture Fund 2Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... chemists at Lehigh University have experimentally verified the "rainbow" ... light waves over a broad range of wavelengths. ... be slowed down or stopped using plasmonic structures has ... The Lehigh experiment employed focused ion beams to mill ...
... Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka ... (EC) has granted marketing authorization for Teysuno™ (S-1), a ... adults with advanced gastric cancer when given in combination ... Member States and the three European Economic Area (EEA) ...
... Co., Inc. (NYSE Amex: TPI ), a ... traditional Chinese medicine, branded generics and other pharmaceuticals is ... Growth Stock Conference from March 13 - 16, 2011 ... Dr. James Jiayuan Tong, Chief Financial Officer, Chief ...
Cached Biology Technology:Trapping a rainbow: Lehigh researchers slow broadband light waves with nanoplasmonic structures 2Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer 2Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer 3TPI Attends 23rd ROTH Annual OC Growth Stock Conference from March 13-16, 2011 2
(Date:7/23/2014)... Migratory songbirds are disappearing, and though conservationists are examining ... habitat, acid rain and light pollution, a key piece ... birds go once they leave their breeding sites, and ... , To answer this question, a team of researchers ... migratory connectivity map produced for a songbird, using tracking ...
(Date:7/23/2014)... around the world have no access to clean drinking ... million people die from water-related diseases every year. ETH ... a contribution to solving this problem. Working with researchers ... the Functional Materials Laboratory, the 23-year-old spent a year ... "What makes our DrinkPure filter unique is that you ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
Breaking Biology News(10 mins):York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2ETH student develops filter for clean water around the world 2Protein evolution follows a modular principle 2
... small nucleus, is the term coined by early biologists ... saw under the microscope. In this structure within the ... ribosomes, the true protein factories of cells. ... diseases, most recently also in neurodegenerative disorders such as ...
... Feb. 1, 2011/PRNewswire-Asia-FirstCall/ -- Weikang Bio-Technology Group Co., ... ("Weikang" or the "Company"), a leading developer, manufacturer ... prescription and OTC pharmaceuticals and other health and ... today announced the completion of its private placement ...
... future diagnosis and treatment of lupus, an immune ... researchers at the Virginia-Maryland Regional College of Veterinary ... the breakdown in the body,s lymphocyte molecular regulatory ... and her colleagues in the veterinary college,s Department ...
Cached Biology News:A possible cause of Parkinson's disease discovered 2Weikang Bio-Technology Announces Completion of $5.0 Million Private Placement 2Weikang Bio-Technology Announces Completion of $5.0 Million Private Placement 3Research uncovers key to understanding cause of lupus 2
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048...
...
Mouse monoclonal antibody raised against a partial recombinant AAAS. NCBI Entrez Gene ID = AAAS...
Rabbit polyclonal to MCP2 ( Abpromise for all tested applications). entrezGeneID: 6355 SwissProtID: P49873...
Biology Products: